Titan Pharmaceuticals
TTNP
#11024
Rank
A$9.05 M
Marketcap
A$6.81
Share price
-3.76%
Change (1 day)
11.92%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -A$4.33 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$6.95 Million, an increase over its 2023 earnings that were of -A$8.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.33 Million-37.78%
2024 -A$6.95 Million-15.5%
2023 -A$8.23 Million-45.43%
2022 -A$15.07 Million16.29%
2021 -A$12.96 Million-907.36%
2020 A$1.6 M-106.6%
2019 -A$24.3 Million82.4%
2018 -A$13.32 Million-36.93%
2017 -A$21.12 Million-378.62%
2016 A$7.58 M-145.53%
2015 -A$16.66 Million369.37%
2014 -A$3.55 Million-125.9%
2013 A$13.69 M-177.74%
2012 -A$17.62 Million13.59%
2011 -A$15.51 Million74.37%
2010 -A$8.9 Million3.61%
2009 -A$8.59 Million
2007 -A$27.22 Million12.08%
2006 -A$24.28 Million-28.65%
2005 -A$34.03 Million-10.03%
2004 -A$37.83 Million-6.08%
2003 -A$40.27 Million-14.76%
2002 -A$47.25 Million32.52%
2001 -A$35.66 Million27.55%
2000 -A$27.96 Million62.5%
1999 -A$17.21 Million4.04%
1998 -A$16.54 Million49.33%
1997 -A$11.08 Million-27.88%
1996 -A$15.36 Million13.04%
1995 -A$13.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.63 B-667,515.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.66 B-450,830.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-A$0.27 Billion 6,242.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$45.28 M-1,193.69%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$15.87 Million 283.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.49 Billion 11,515.97%๐Ÿ‡บ๐Ÿ‡ธ USA